Orthostatic hypertension

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Orthostatic hypertension
Other namesPostural hypertension

Orthostatic hypertension, is a medical condition consisting of a sudden and abrupt increase in blood pressure when a person stands up.[1] Orthostatic hypertension is diagnosed by a rise in systolic blood pressure of 20 mmHg or more when standing. Orthostatic diastolic hypertension is a condition in which the diastolic raises to 98 mmHg or over in response to standing;[2][3] however, this definition currently lacks clear medical consensus and is thus subject to change. Orthostatic hypertension involving the systolic is known as systolic orthostatic hypertension.

If affecting an individual's ability to remain upright, orthostatic hypertension is viewed as a form of orthostatic intolerance. The body's inability to regulate the blood pressure can be a type of dysautonomia.

Baroreflex and autonomic pathways normally ensure that blood pressure is maintained despite various stimuli including postural change. The precise mechanism of orthostatic hypertension remains unclear, but it is thought that alpha-adrenergic activity may be the predominant pathophysiologic mechanism of orthostatic hypertension in elderly hypertensive patients.[4] Other mechanisms are proposed for other different groups of individuals with this disorder.[1]

A prevalence of 1.1% was found in a large population study.[5] The risk of orthostatic hypertension has been found to increase with age, with it being found in 16.3% of older hypertensive patients.[6]


  • Mild or moderate orthostatic hypertension may present without any symptoms other than the orthostatic hypertension BP findings. More severe orthostatic hypertension may present with the typical symptoms of hypertension.
  • Orthostatic venous pooling is common with orthostatic diastolic hypertension. This occurs in the legs while standing.[7][8]

Connections to other disorders[edit]


  • Blood pressure variability is associated with progression of target organ damage and cardiovascular risk.[13]
  • Orthostatic hypertension was positively associated with peripheral arterial disease.[6]
  • Increased occurrence of silent cerebrovascular ischemia[1][4]
  • Systolic orthostatic hypertension increases stroke risk.[14]


The condition can be assessed by a tilt table test. If the test is positive the diagnosis is hyperadrenergic postural orthostatic tachycardia syndrome.


There is not any official recommended treatments currently for orthostatic hypertension as the condition is still little known and can be due to different causes, hence treatment for those with this disorder is still trial and error experimental treatment. Some treatments which have been successfully used for this condition are medications doxazosin,[15] carvedilol,[16] captopril, and propranolol hydrochloride. Treatment of coexisting conditions, e.g., hypovolemia. Some specialists in severe cases give saline IVs for the hypovolemia which then if that is the cause, brings the orthostatic hypertension down to a safe level. Pressure garments over the pelvis and the lower extremeties may be used as part of treatment, due to the blood pooling issue happening in many with the disorder.[7]


  1. ^ a b c d Fessel, J.; Robertson, D. (2006). "Orthostatic hypertension: When pressor reflexes overcompensate". Nature Clinical Practice Nephrology. 2 (8): 424–431. doi:10.1038/ncpneph0228. PMID 16932477.
  2. ^ Bell, David S. (May 2000). "Orthostatic Intolerance (OI) Test Results". Lyndonville News. 2 (3).
  3. ^ Streeten, D.H.P. (1987). Orthostatic Disorders of the Circulation. New York: Plenum Medical. p. 116.
  4. ^ a b Kario, K.; Eguchi, K.; Hoshide, S.; Hoshide, Y.; Umeda, Y.; Mitsuhashi, T.; Shimada, K. (2002). "U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: Orthostatic hypertension as a new cardiovascular risk factor". Journal of the American College of Cardiology. 40 (1): 133–141. doi:10.1016/S0735-1097(02)01923-X. PMID 12103267.
  5. ^ Wu, J. S.; Yang, Y. C.; Lu, F. H.; Wu, C. H.; Chang, C. J. (2008). "Population-Based Study on the Prevalence and Correlates of Orthostatic Hypotension/Hypertension and Orthostatic Dizziness". Hypertension Research. 31 (5): 897–904. doi:10.1291/hypres.31.897. PMID 18712045.
  6. ^ a b Fan, X. H.; Sun, K.; Zhou, X. L.; Zhang, H. M.; Wu, H. Y.; Hui, R. T. (2011). "Association of orthostatic hypertension and hypotension with target organ damage in middle and old-aged hypertensive patients". Zhonghua Yi Xue Za Zhi. 91 (4): 220–224. PMID 21418863.
  7. ^ a b Streeten, D. H.; Auchincloss Jr, J. H.; Anderson Jr, G. H.; Richardson, R. L.; Thomas, F. D.; Miller, J. W. (1985). "Orthostatic hypertension. Pathogenetic studies". Hypertension. 7 (2): 196–203. doi:10.1161/01.hyp.7.2.196. PMID 3980066.
  8. ^ Streeten, D. H.; Anderson Jr, G. H.; Richardson, R.; Thomas, F. D. (1988). "Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: Evidence for excessive venous pooling". The Journal of Laboratory and Clinical Medicine. 111 (3): 326–335. PMID 3343547.
  9. ^ Benowitz, N. L.; Zevin, S.; Carlsen, S.; Wright, J.; Schambelan, M.; Cheitlin, M. (1996). "Orthostatic hypertension due to vascular adrenergic hypersensitivity". Hypertension. 28 (1): 42–46. doi:10.1161/01.hyp.28.1.42. PMID 8675262.
  10. ^ Tsukamoto, Y.; Komuro, Y.; Akutsu, F.; Fujii, K.; Marumo, F.; Kusano, S.; Kikawada, R. (1988). "Orthostatic hypertension due to coexistence of renal fibromuscular dysplasia and nephroptosis". Japanese Circulation Journal. 52 (12): 1408–1414. doi:10.1253/jcj.52.1408. PMID 2977192.
  11. ^ Takada, Y.; Shimizu, H.; Kazatani, Y.; Azechi, H.; Hiwada, K.; Kokubu, T. (1984). "Orthostatic hypertension with nephroptosis and aortitis disease". Archives of Internal Medicine. 144 (1): 152–154. doi:10.1001/archinte.144.1.152. PMID 6362595.
  12. ^ Miranda CL, Henderson MC, Wang JL, Nakaue HS, Buhler DR (1986). "Induction of acute renal porphyria in Japanese quail by Aroclor 1254". Biochem. Pharmacol. 35 (20): 3637–9. doi:10.1016/0006-2952(86)90637-4. PMID 3094542.
  13. ^ Kario, K. (2009). "Orthostatic hypertension: A measure of blood pressure variation for predicting cardiovascular risk". Circulation Journal. 73 (6): 1002–1007. doi:10.1253/circj.cj-09-0286. PMID 19430163.
  14. ^ Yatsuya, H.; Folsom, A. R.; Alonso, A.; Gottesman, R. F.; Rose, K. M.; Aric Study, I. (2011). "Postural changes in blood pressure and incidence of ischemic stroke subtypes: The ARIC study". Hypertension. 57 (2): 167–173. doi:10.1161/HYPERTENSIONAHA.110.161844. PMC 3214760. PMID 21199999.
  15. ^ Hoshide, S.; Parati, G.; Matsui, Y.; Shibazaki, S.; Eguchi, K.; Kario, K. (2011). "Orthostatic hypertension: Home blood pressure monitoring for detection and assessment of treatment with doxazosin". Hypertension Research. 35 (1): 100–6. doi:10.1038/hr.2011.156. PMID 21918522.
  16. ^ Moriguchi, A.; Nakagami, H.; Kotani, N.; Higaki, J.; Ogihara, T. (2000). "Contribution of cardiovascular hypersensitivity to orthostatic hypertension and the extreme dipper phenomenon". Hypertension Research. 23 (2): 119–123. doi:10.1291/hypres.23.119. PMID 10770258.